Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process

Cancer Research

Volumn 62, Issue 23, 2002, Pages 7042-7049

  Barbera Guillem, Emilio ^a,b   Nyhus, Julie K ^a   Wolford, Chris C ^a   Friece, Chad R ^a   Sampsel, James W ^a  

^a BioCrystal Ltd   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MESSENGER RNA; PROTEIN SUBUNIT; SILVER; VASCULOTROPIN; VASCULOTROPIN C;

ANGIOGENESIS; ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BREAST CARCINOMA; CELL CULTURE; CELL INTERACTION; COLON CARCINOMA; CONTROLLED STUDY; ENDOCYTOSIS; FEMALE; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOPEROXIDASE STAINING; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; NUDE MOUSE; PHAGOSOME; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR BIOPSY; TUMOR CELL; TUMOR GROWTH; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, NEOPLASM; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BREAST NEOPLASMS; CELL COMMUNICATION; COLONIC NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOGLOBULIN G; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MACROPHAGES; MICE; MICE, INBRED C3H; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036895601     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Yoshikawa, T., Tsuburaya, A., Kobayashi, O., Sairenji, M., Motohashi, H., Yanoma, S., and Noguchi, Y. Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma. Cancer Lett., 153: 7-12, 2000.
2. Komorowski, J., Jankewicz, J., and Stepien, H. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours. Cytobios, 101: 151-159, 2000.
3. Edgren, M., Lennernas, B., Larsson, A., and Nilsson, S. Serum concentrations of VEGF and b-FGF in renal cell, prostate and urinary bladder carcinomas. Anticancer Res., 19: 869-873, 1999.
4. Fuhrmann Benzakein, E., Ma, M. N., Rubbia Brandt, L., Mentha, G., Ruefenacht, D., Sappino, A. P., and Pepper, M. S. Elevated levels of angiogenic cytokines in the plasma of cancer patients. Int. J. Cancer, 85: 40-45, 2000.
5. Detmar, M., Velasco, P., Richard, L., Claffey, K. P., Streit, M., Riccardi, L., Skobe, M., and Brown, L. F. Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas. Am. J. Pathol., 156: 159-167, 2000.
6. Kondo, Y., Arii, S., Mori, A., Furutani, M., Chiba, T., and Imamura, M. Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line. Clin. Cancer Res., 6: 622-630, 2000.
7. Lewin, M., Bredow, S., Sergeyev, N., Marecos, E., Bogdanov, A., Jr., and Weissleder, R. In vivo assessment of vascular endothelial growth factor-induced angiogenesis. Int. J. Cancer, 83: 798-802, 1999.
8. Aonuma, M., Saeki, Y., Akimoto, T., Nakayama, Y., Hattori, C., Yoshitake, Y., Nishikawa, K., Shibuya, M., and Tanaka, N. G. Vascular endothelial growth factor overproduced by tumour cells acts predominantly as a potent angiogenic factor contributing to malignant progression. Int. J. Exp. Pathol., 80: 271-281, 1999.
9. Williams, C. S., Tsujii, M., Reese, J., Dey, S. K., and DuBois, R. N. Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Investig., 105: 1589-1594, 2000.
10. Decaussin, M., Sartelet, H., Robert, C., Moro, D., Claraz, C., Brambilla, C., and Brambilla, E. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): Correlation with angiogenesis and survival. J. Pathol., 188: 369-377, 1999.
11. Nagashima, G., Suzuki, R., Hokaku, H., Takahashi, M., Miyo, T., Asai, J., Nakagawa, N., and Fujimoto, T. Graphic analysis of microscopic tumor cell infiltration, proliferative potential, and vascular endothelial growth factor expression in an autopsy brain with glioblastoma. Surg. Neurol., 51: 292-299, 1999.
12. Rossler, J., Breit, S., Havers, W., and Schweigerer, L. Vascular endothelial growth factor expression in human neuroblastoma: up-regulation by hypoxia. Int. J. Cancer, 81: 113-117, 1999.
13. Danielsen, T., and Rofstad, E. K. The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF up-regulation in the angiogenesis of human melanoma xenografts. Br. J. Cancer, 82: 1528-1534, 2000.
14. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328, 1994.
15. Cameron, M. D., Schmidt, E. E., Kerkvliet, N., Nadkarni, K. V., Morris, V. L., Groom, A. C., Chambers, A. F., and MacDonald, I. C. Temporal progression of metastasis in lung: Cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res., 60: 2541-2546, 2000.
16. Sawatsubashi, M., Yamada, T., Fukushima, N., Mizokami, H., Tokunaga, O., and Shin, T. Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch., 436: 243-248, 2000.
17. Dankbar, B., Padro, T., Leo, R., Feldmann, B., Kropff, M., Mesters, R. M., Serve, H., Berdel, W. E., and Kienast, J. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood. 95: 2630-2636, 2000.
18. Torisu, H., Ono, M., Kiryu, H., Furue, M., Ohmoto, Y., Nakayama, J., Nishioka, Y., Sone, S., and Kuwano, M. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNF-α and IL-1α. Int. J. Cancer, 85: 182-188, 2000.
19. Gavin, T. P., Spector, D. A., Wagner, H., Breen, E. C., and Wagner, P. D. Nitric oxide synthase inhibition attenuates the skeletal muscle VEGF mRNA response to exercise. J. Appl. Physiol., 88: 1192-1198, 2000.
20. Richardson, R. S., Wagner, H., Mudaliar, S. R., Henry, R., Noyszewski, E. A., and Wagner, P. D. Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise. Am. J. Physiol., 277: H2247-H2252, 1999.
21. Steinbrech, D. S., Mehrara, B. J., Chau, D., Rowe, N. M., Chin, G., Lee, T., Saadeh, P. B., Gittes, G. K., and Longaker, M. T. Hypoxia upregulates VEGF production in keloid fibroblasts. Ann. Plast. Surg., 42: 514-519, discussion, 519-520, 1999.
22. Edelman, J. L., Castro, M. R., and Wen, Y. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. Investig. Ophthalmol. Vis. Sci., 40: 1112-1123, 1999.
23. Goede, V., Brogelli, L., Ziche, M., and Augustin, H. G. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int. J. Cancer, 82: 765-770, 1999.
24. Frank, S., Stallmeyer, B., Kampfer, H., Kolb, N., and Pfeilschifter, J. Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J., 13: 2002-2014, 1999.
25. Levitas, E., Chamoun, D., Udoff, L. C., Ando, M., Resnick, C. E., and Adashi, E. Y. Periovulatory and interleukin-1β-dependent up-regulation of intraovarian vascular endothelial growth factor (VEGF) in the rat: Potential role for VEGF in the promotion of periovulatory angiogenesis and vascular permeability. J. Soc. Gynecol. Investig., 7: 51-60, 2000.
26. El Awad, B., Kreft, B., Wolber, E. M., Hellwig Burgel, T., Metzen, E., Fandrey, J., and Jelkmann, W. Hypoxia and interleukin-1β stimulate vascular endothelial growth factor production in human proximal tubular cells. Kidney Int., 58: 43-50, 2000.
27. Itzkowitz, S. H., Yuan, M., Montgomery, C. K., Kjeldsen, T., Takahashi, H. K., Bigbee, W. L., and Kim, Y. S. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res., 49: 197-204, 1989.
28. Zhang, S., Walberg, L. A., Ogata, S., Itzkowitz, S. H., Koganty, R. R., Reddish, M., Gandhi, S. S., Longenecker, B. M., Lloyd, K. O., and Livingston, P. O. Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen. Cancer Res., 55: 3364-3368, 1995.
29. Thor, A., Ohuchi, N., Szpak, C. A., Johnston, W. W., and Schlom, J. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res., 46: 3118-3124, 1986.
30. Sheer, D. G., Schlom, J., and Cooper, H. L. Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3. Cancer Res., 48: 6811-6818, 1988.
31. Nyhus, J. K., Wolford, C. C., Friece, C. R., Nelson, B., Sampsel, J. W., and Barbera-Guillem, E. IgG-recognizing shed tumor-associated antigens can promote tumor invasion and metastasis. Cancer Immunol. Immunother., 50: 361-372, 2001.
32. Barbera-Guillem, E., May, K. F., Jr., Nyhus, J. K., and Nelson, M. B. Promotion of tumor invasion by cooperation of granulocytes and macrophages activated by antitumor antibodies. Neoplasia, 1: 453-460, 1999.
33. Rak, J., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R. S. Mutant ras oncogenes up regulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis. Cancer Res., 55: 4575-4580, 1995.
34. Yoshiji, H., Gomez, D. E., Shibuya, M., and Thorgeirsson, U. P. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res., 56: 2013-2016, 1996.
35. Presta, L. G., Chen, H., O'Connor, S. J., Chisholm, V., Meng, Y. G., Krummen, L., Winkler, M., and Ferrara, N. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res., 57: 4593-4599, 1997.
36. Saleh, M., Stacker, S. A., and Wilks, A. F. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res., 56: 393-401, 1996.
37. Borgstrom, P., Hillan, K. J., Sriramarao, P., and Ferrara, N. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: Novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res., 56: 4032-4039, 1996.
38. Verheul, H. M., Hoekman, K., Luykx-de Bakker, S., Eekman, C. A., Folman, C. C., Broxterman, H. J., and Pinedo, H. M. Platelet: Transporter of vascular endothelial growth factor. Clin. Cancer Res., 3: 2187-2190, 1997.
39. Wartiovaara, U., Salven, P., Mikkola, H., Lassila, R., Kaukonen, J., Joukov, V., Orpana, A., Ristimaki, A., Heikinheimo, M., Joensuu, H., Alitalo, K., and Palotie, A. Peripheral blood platelets express VEGF-C and VEGF, which are released during platelet activation. Thromb. Haemostasis, 80: 171-175, 1998.
40. Salven, P., Orpana, A., and Joensuu, H. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin. Cancer Res., 5: 487-491, 1999.
41. Xiong, M., Elson, G., Legarda, D., and Leibovich, S. J. Production of vascular endothelial growth factor by murine macrophages: Regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am. J. Pathol., 153: 587-598, 1998.
42. Kranz, A., Mattfeldt, T., and Waltenberger, J. Molecular mediators of tumor angiogenesis: Enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer. Int. J. Cancer, 84: 293-298, 1999.
43. van Ravenswaay Claasen, H. H., Kluin, P. M., and Fleuren, G. J. Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity. Lab. Investig., 67: 166-174, 1992.
44. Brunda, M. J., Sulich, V., Wright, R. B., and Palleroni, A. V. Tumoricidal activity and cytokine secretion by tumor-infiltrating macrophages. Int. J. Cancer, 48: 704-708, 1991.
45. Caruso, R. A., Vitullo, P., Modesti, A., and Inferrera, C. Small early gastric cancer with special reference to macrophage infiltration. Mod. Pathol., 12: 386-390, 1999.
46. Lu, B., Rutledge, B. J., and Gu, L. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med., 187: 601-608, 1998.
47. Hemmerlein, B., Johanns, U., Kugler, A., Reffelmann, M., and Radzun, H. J. Quantification and in situ localization of MCP-1 mRNA and its relation to the immune response in renal cell carcinoma. Cytokine, 13: 227-233, 2001.
48. Ueno, T., Toi, M., Saji, H., Muta, M., Bando, H., Kuroi, K., Koike, M., Inadera, H., and Matsushima, K. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin. Cancer Res., 6: 3282-3289, 2000.
49. Shanley, T. P., Schmal, H., Warner, R. L., Schmid, E., Friedl, H. P., and Ward, P. A. Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. J. Immunol., 158: 3439-3448, 1997.
50. Dubuisson, L., Bioulac-Sage, P., Boussarie, L., Quinton, A., Saric, J., de Mascarel, A., and Balabaud, C. Removal of cellular debris formed in the Disse space in patients with cholestasis. Virchows Arch. A Pathol. Anat. Histopathol., 410: 501-507, 1987.
51. Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K., and Alitalo, K. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (Wash. DC), 276: 1423-1425, 1997.
52. Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., and Detmar, M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med., 7: 192-198, 2001.
53. Swift, M. E., Kleinman, H. K., and DiPietro, L. A. Impaired wound repair and delayed angiogenesis in aged mice. Lab. Investig., 79: 1479-1487, 1999.
54. Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., and Wiegand, S. J. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science (Wash. DC), 284: 1994-1998, 1999.
55. Bansal, S. C., Bansal, B. R., Thomas, H. L., Siegel, P. D., Rhoads, J. E., Jr., Cooper, D. R., Terman, D. S., and Mark, R. Ex vivo removal of serum IgG in a patient with colon carcinoma: Some biochemical, immunological and histological observations. Cancer (Phila.), 42: 1-18, 1978.
56. Canevari, S., Pupa, S. M., and Menard, S. 1975-1995 Revised anti-cancer serological response: biological significance and clinical implications. Ann. Oncol., 7: 227-232, 1996.
57. Lee, Y. T., Sheikh, K. M., Quismorio, F. P., Jr., and Friou, G. J. Circulating anti-tumor and autoantibodies in breast carcinoma: Relationship to stage and prognosis. Breast Cancer Res. Treat., 6: 57-65, 1985.